X4 Pharmaceuticals (XFOR) Earnings (2017 - 2026)
X4 Pharmaceuticals (XFOR) earnings from Mar 31, 2017 to Mar 31, 2026. The TTM X4 Pharmaceuticals (XFOR) earnings is -$100M. You can adjust inflation or export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Annual Earnings
Quarterly Earnings
X4 Pharmaceuticals (XFOR) Earnings CAGR table
| Period | CAGR |
|---|---|
| 3 Years TTM | +1.30% |
| 5 Years TTM | +7.43% |
| All Time TTM | +19.50% |
Annual Earnings change of X4 Pharmaceuticals (XFOR)
| Year | Earnings | Change |
|---|---|---|
| 2026 | -$20M | -74.44% |
| 2025 | -$79M | +111.48% |
| 2024 | -$37M | -62.98% |
| 2023 | -$101M | +7.78% |
| 2022 | -$94M | +5.83% |
| 2021 | -$89M | +42.77% |
| 2020 | -$62M | +17.65% |
| 2019 | -$53M | +58.68% |
| 2018 | -$33M | +51.34% |
| 2017 | -$22M | -4.27% |
| 2016 | -$23M | N/A |
Comparison X4 Pharmaceuticals (XFOR) five years earnings CAGR with competitors
X4 Pharmaceuticals (XFOR) five years earnings CAGR is 7.44%.